Veterinary and Comparative Oncology

Papers
(The TQCC of Veterinary and Comparative Oncology is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Issue Information31
Issue Information31
Timely adjuvant chemotherapy improves outcome in dogs with non‐metastatic splenic hemangiosarcoma undergoing splenectomy18
Serum thymidine kinase 1 activity as a prognostic biomarker in dogs with chemotherapy‐treated diffuse large B‐cell lymphoma17
Effects of a high‐protein, increased‐fibre, dry diet supplemented with omega‐3 fatty acids on quality of life in dogs undergoing chemotherapy17
Ultrasound‐guided core needle biopsy in dogs with thyroid carcinoma15
Investigation of efficacy of two different chemotherapy protocols used in neoadjuvant chemotherapy in clinical stages II–IV canine malignant mammary tumours15
Treatment of feline intermediate to high‐grade alimentary lymphoma: A retrospective evaluation of 55 cats treated with the VAPC combination chemotherapy protocol (2017–2021)15
Outcomes of 35 dogs with craniomaxillofacial osteosarcoma treated with stereotactic body radiation therapy13
High lysyl oxidase expression is an indicator of poor prognosis in dogs with cutaneous mast cell tumours13
Dysregulated miRNAs in a canine model of haemangiosarcoma metastatic to the brain13
Descriptive analysis of haemangiosarcoma occurrence in dogs enrolled in the Golden Retriever lifetime study12
Prognostic Significance of Tumour Infiltrating Lymphocytes in Canine Oral Malignant Melanoma Treated With Anti‐Programmed Cell Death Ligand 1 ( PD ‐ 12
Pre‐operative neoadjuvant vinblastine‐prednisolone in canine mast cell tumours: A single‐centre retrospective cohort study12
Dose and Duration of Upfront Steroid Administration Have no Prognostic Impact in Dogs With Multicentric Diffuse Large B‐Cell Lymphoma12
Plasma cell‐free DNA in canine lymphoma patients as a novel material for genotyping12
Outcome of dogs treated with chemotherapy for mesothelioma: A retrospective clinical study on 40 cases and a literature review11
Combining radiation therapy with zoledronate for the treatment of osteo‐invasive feline oral squamous cell carcinoma10
10
Efficacy and toxicity of carboplatin in the treatment of macroscopic mesenchymal neoplasia in dogs10
Blood biomarkers for canine cancer, from human to veterinary oncology10
Cross‐Species Transcriptomic and Network Analysis of Human and Canine Diffuse Large B‐Cell Lymphoma Identifies a Conserved Replication– DNA Damage Mo10
Issue Information10
Issue Information10
Polarisation Sensitive Optical Coherence Tomography Image Characteristics for Gastrointestinal Tumours and Normal Tissues at Surgical Margins in Dogs10
Issue Information10
Issue Information10
Prognostic Value of a Histopathological Scoring System and the Ki67 Proliferation Index in Dogs With Phaeochromocytoma9
Use of Cystourethroscopy to Define the Gross Tumour Volume in Radiation Treatment Planning for Canine Genitourinary Carcinomas9
Effects of Lipophilic Statins on Cell Viability and Tissue Factor Expression in Canine Haemangiosarcoma Cells9
Author Index9
9
Immunophenotyping and Mutation Analysis of Canine Intestinal T‐Cell Lymphoma: A Comparative Pathological Study of Human Enteropathy‐Associated T‐Cell Lymphoma9
Chronic adrenergic stress and generation of myeloid‐derived suppressor cells: Implications for cancer immunotherapy in dogs9
8
Issue Information8
Fractionated oral dosing and its effect on cyclophosphamide pharmacokinetics in dogs with high‐grade multicentric lymphoma8
Frontal sinus carcinoma in forty‐one dogs (2001–2022)8
Classification and Prognostication of B‐Cell and T‐Cell Multicentric Lymphoma in Dogs Using Serum MicroRNAs8
Epidemiology of canine cutaneous round cell tumours on the canary archipelago in Spain8
8
Spotlight on capecitabine for the treatment of unresectable or metastatic carcinoma of various origin: A retrospective study of 25 dogs8
7
Author Index7
7
Blood Neutrophil‐to‐Lymphocyte Ratio as a Potential Prognostic Marker in Dogs ≤10 kg With Multicentric Lymphoma7
DNA Methylation and Its Effects on TRIM29 Gene Expression in the Eq7
Use of Lomustine and Prednisolone as First‐Line Treatment in Canine Multicentric Lymphoma7
Evaluation of the health‐related quality of life in dogs following intracranial meningioma resection using a specifically developed questionnaire6
Configuration of pathologic fractures in dogs with osteosarcoma following stereotactic body radiation therapy: A retrospective analysis6
Retrospective analysis of outcome and prognostic factors of subcutaneous mast cell tumours in dogs undergoing surgery with or without adjuvant treatment6
6
Quantification of circulating tumour cells over time in dogs with appendicular osteosarcoma6
Phase 1 Dose Escalation of Single‐Agent Mechlorethamine in Dogs With Lymphoma6
Favourable Prognostic Significance of HER2 Mutations in Canine Pulmonary Adenocarcinoma Following 6
Evaluation of serum interleukin 2 receptor and beta‐2‐microglobulin as prognostic factors for canine lymphoma: A pilot study6
Serum Lactate Dehydrogenase as a Potential Prognostic Biomarker in Dogs With Appendicular Osteosarcoma6
Comparison of the anticancer effects of various statins on canine oral melanoma cells6
Defining the relevance of surgical margins. Part two: Strategies to improve prediction of recurrence risk6
Critical Questions in Genomic Diagnostics for Veterinary Oncology: What We Need to Know6
Overactivation of Signal Transducer and Activator of Transcription 3 in Canine Hepatocellular Carcinoma and Its Prognostic Significance6
Description and efficacy of a response‐based “QUAD” cyclical hypofractionated palliative‐intent radiation protocol in dogs with macroscopic solid tumours: 108 cases5
Impact of 10% Dose Reductions and Duration of Treatment Delays in the Management of Chemotherapy‐Induced Neutropenia in Dogs Treated With Common Chemotherapy Protocols: A Single‐Centre Experience5
Rescue Protocols for Canine Non‐Indolent B Cell Lymphoma: A Systematic Review5
5
Molecular Classification Based on the Gene Expression Profiles in Canine Histiocytic Sarcoma Cells5
Sodium iodide symporter immunolabelling as a predictor of clinical iodide uptake in canine thyroid carcinoma: A preliminary study5
Vinorelbine as a Rescue Treatment for Canine Histiocytic Sarcoma: A Multicentre Retrospective Study of 18 Dogs5
Isolation of Tumour‐Derived Extracellular Vesicles From the Plasma of Dogs Affected by Intracranial Tumours Showing Heterologous and Cross‐Species Tropism: A Pilot Study5
Sentinel lymph node mapping in canine mast cell tumours using a preoperative radiographic indirect lymphography: Technique description and results in 138 cases5
Clinical Response to Imatinib Mesylate and Toxicity Profile in 35 Dogs With Mast Cell Tumours5
Evaluating VEGFR2 as a Target for Anti‐Tumour Therapy in Canine Melanoma5
Stereotactic body radiation therapy as an alternative to adrenalectomy for the treatment of pheochromocytomas in 8 dogs5
Cyclical 10‐day dosing of melphalan for canine multiple myeloma4
VCS abstract4
Half‐Body Radiation Therapy Results in a Prolonged Progression‐Free Interval in Canine High‐Grade Lymphoma After First Remission4
A Multi‐Institutional Retrospective Study of 21 Dogs Having Undergone Hypofractionated Radiotherapy for Adrenal Tumours (2017–2024)4
Newcastle disease virus LaSota strain induces apoptosis and activates the TNFα/NF‐κB pathway in canine mammary carcinoma cells4
The animal's microbiome and cancer: A translational perspective4
Comprehensive Analysis of the Tumour Immune Microenvironment in Canine Urothelial Carcinoma Reveals Immunosuppressive Mechanisms Induced by the COX–Prostanoid Cascade4
Hotspot Exon 15 Mutations in BRAF Are Uncommon in Feline Tumours4
Correction to “ DNA Methylation and Its Effects on TRIM29 Gene Expression in the Equine Sarcoid Ti4
Correlation between computed tomography and histological evaluation of nodal metastasis in dogs with mast cell tumours4
Evaluating the relevance of surgical margins. Part one: The problems with current methodology4
Comparative Response of Canine and Human Osteosarcoma Tumour Cell Lines to Molecularly Targeted Anticancer Agents at Clinically Relevant Exposures With Analysis of Genomic Biomarkers4
Clinical outcomes in cats with renal carcinoma undergoing nephrectomy: A retrospective study4
Prognostic significance of CD25 expression in dogs with a noninvasive diagnosis of B‐cell lymphoma treated with CHOP chemotherapy4
Evaluation of mechlorethamine, vinblastine, procarbazine, and prednisone for the treatment of resistant multicentric canine lymphoma4
Immunological Pre‐Metastatic Niche in Dogs With Naturally Occurring Osteosarcoma4
Sentinel lymph node mapping with computed tomography lymphography for mast cell tumours and a comparison between regional and sentinel lymph node histological status: Sixty‐two cases4
Mass spectrometric‐based assessment of the serum kappa to lambda immunoglobulin light chain ratio (κ:λ) in dogs with immunoglobulin secretory diseases4
Machine Learning‐Based Risk Prediction for Feline Mammary Tumours: A Comprehensive Epidemiological Analysis Using Multi‐Model Ensemble Approach4
Issue Information4
Proteasome Inhibitor–Induced Cytotoxic Mechanisms in Canine Pulmonary Adenocarcinoma Cell Lines4
A retrospective study of canine oral extramedullary plasmacytoma over a 15‐year period (July 2004–July 2019): Treatment, histologic parameters and clinical outcomes4
0.26462507247925